Carl Christoph Schimanski

High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells

Carl Christoph Schimanski, Kirsten Frerichs, Fareed Rahman et al. · World Journal of Gastroenterology · 2009 · 201 citations · Full text

Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—a randomized phase II trial of the AIO pancreatic cancer group

Thomas Seufferlein, Waldemar Uhl, Marko Kornmann et al. · Annals of Oncology · 2022 · 146 citations · Full text

Surgical Oncology, Pancreatic Cancer, Phase Ii Trial +6

Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell lines

Annett Mueller, Erika Bachmann, Monika Linnig et al. · Cancer Chemotherapy and Pharmacology · 2012 · 75 citations

Gastrointestinal Oncology, Medicine, Pharmacology +5

Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease

Felix Wolfert, Carl Christoph Schimanski, Ines Gockel et al. · Oncology Reports · 2006 · 68 citations · Full text

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program

Markus Moehler, Irina Gepfner‐Tuma, Annett Maderer et al. · BMC Cancer · 2016 · 65 citations · Full text